top of page

Exosomes Therapy


Personalized Therapy Treatments

Exosome therapy is a new approach in medicine that uses tiny particles, called exosomes, to help the body heal itself. These exosomes are taken from cells and used to treat different health issues, focusing on natural healing and rejuvenation. It's a promising area of research, with potential benefits in various treatments, from anti-aging to healing chronic diseases. This therapy is still in the early stages of research, but it's gaining attention for its innovative and natural approach to health and wellness.


Exosomes Therapy Benefits:

  • Enhances Cellular Communication

  • Regenerative Capabilities

  • Versatility in Treatment

  • Targeted Drug Delivery

  • Neurological Benefits

  • Promotes Natural Healing

  • Anti-Aging Properties

  • Supports Immune Function

  • Potential in Chronic Disease Management

  • Minimal Invasiveness

Stacked Rocks

Musculoskeletal Disorders/Injuries

Autoimmune Disorders


MS, Alzheimer's, Parkinsons

Burns, Scars, Ulcers

Heart Disease

Lung Diseases

Liver Disease

Kidney Disease

Inflammatory Bowel Disease

Cerebral Palsy, Autism

Neuropathy, CIDP


Urinary Incontinence

Complex Regional Pain Syndrome

Chronic Pelvic Pain

Lyme Disease

Numerous Aesthetic Applications

Who May Benefit from Exosomes

rocks stacked

 Exosomes Explained

Bubble Background


  •   The effectiveness of exosome therapy can vary by patient. Some studies show its benefits lasting for years. Results depend on the individual's specific health issues and condition. Some might need just 1-2 sessions, while others require ongoing treatment for the best outcome. The time it takes to see results also differs as some may see immediate improvements, and others might notice changes 3-6 months after treatment.

  • Exosomes, being smaller in size, hold great promise as vehicles for delivering therapeutic cargos systemically throughout the body, a challenge often faced by larger stem cells. These nano-sized vesicles can efficiently cross the blood-brain barrier, precisely targeting specific cells and tissues.


    In contrast to stem cells, Exosomes lack the inherent capability to transform into various cell types. Instead, their influence is exerted through the delivery of their cargo to target cells, where they adjust cellular functions and stimulate the processes of tissue regeneration.


    Unlike stem cells, Exosomes do not carry live DNA. Remarkably, a significant portion of the therapeutic benefits attributed to stem cells actually stem from the actions of the exosomes they release. This feature sets exosomes apart as a superior choice, offering a safe and highly effective approach to tissue repair and rejuvenation.

  • In the field of exosome research, some manufacturers employ a preservation technique known as "lyophilization." Lyophilization is essentially a sophisticated drying process that removes water from exosomes through sublimation. This involves first freezing the sample and then applying a vacuum to facilitate the direct transition of water from solid (ice) to gas (vapor).


    However, there's a critical drawback to this method. The cell membrane of exosomes includes a delicate structure known as the bilipid layer, which is highly sensitive to such processes. Lyophilization can disrupt this layer, potentially compromising the integrity of the exosomes. While lyophilization allows the exosomes to remain stable at room temperature, rehydrating (or reconstituting) them often doesn’t restore their original chemical structure or functionality.


    The process also introduces additional chemicals, leading to a product that isn’t completely pure. From a practical standpoint, lyophilization can create operational inefficiencies and disrupt clinical workflow.


    Current scientific evidence does not support the notion that lyophilized exosomes retain the same functional payload, specifically their mRNA and miRNA content, as their non-lyophilized counterparts. No empirical studies in the lyophilized exosome field have yet demonstrated that these vital components remain effective after the process.


    For these reasons, our exosome research lab has decided against incorporating lyophilization into our manufacturing process.

    • A standard PRP injection typically provides a maximum of 12 growth factors to the treatment area.

    • In contrast, exosome injections may deliver a significantly higher number, with approximately 700 growth factors.

    • Exosome therapy is potentially about 60 times more powerful and more effective than PRP treatment.

  • In general, inflammatory agents can compromise effectiveness, and PRP is considered one such agent due to its inflammatory properties. This creates a challenge where treatments may counteract each other, leading to potential hindrances. It can be likened to using a mix of outdated and new, high-performing components together.


    When PRP is injected or transfused, it triggers inflammation in the surrounding tissues, causing a misdirection of exosomes to unintended areas, impacting their ability to function optimally.


    Essentially, this issue arises from the inflammation caused by PRP, which leads to exosomes being diverted to the wrong locations, resulting in suboptimal outcomes.

  • Exosomes, which occur naturally in the body, have a lower risk of causing bad reactions to drugs. Our lab tested them at high concentrations thrice a month and found no toxic effects. This suggests that exosomes could be safe even in large amounts. However, the maximum safe dosage for exosome therapy isn't set yet. Once the FDA approves exosomes as drugs, the dosage will vary based on the particular medical condition being treated. The following conditions and treatments contraindicate the use of exosomes:

    • Recreational drugs, including alcohol and prescribed opioids

    • Blood thinning medications or NSAIDs

    • For facial treatment, certain skin care products, especially retinoids and acid-based products such as glycolic acid and salicylic acid, must be avoided one week prior to and two weeks following facial treatments.

    • Other inflammatory agents.

  • Submission of a Drug Master File demonstrates the manufacturer’s commitment to regulatory compliance and quality assurance. It ensures that the FDA has access to the necessary information to assess the safety and potency of the product, as well as manufacturing practices and processes.

  • A third-party virology report for exosomes is crucial for verifying their safety and equality.All batches provided by the manufacturer we contract with are tested by a third-party testing company to mitigate the risk of viral contamination. The

    report adds transparency and assurance to the development and use of our exosomes.

Beach with sea glasson drftwood

Request a Consultation

Services Interested In:
services interested additional choices
bottom of page